Another woman has joined the thousands of individuals who have filed Lipitor lawsuits against Pfizer Inc., claiming the drug causes type-2 diabetes.

Plaintiff Wanda F.’s Lipitor diabetes lawsuit filed on Aug. 4, is now part of a multidistrict litigation (MDL) that is taking place in the U.S. District Court for the District of South Carolina Charleston Division.

Wanda, 57, began taking Liptor in 1993 and discontinued its use in June. She was diagnosed with type-2 diabetes in 1999. The plaintiff alleges that she suffered grievous bodily injury, economic and other losses, pain, suffering, emotional distress and loss of enjoyment of life.

Like Lipitor patients who have filed similar lawsuits, Wanda alleges that Pfizer was negligent in multiple areas, did not adequately warn her of the adverse effects of the medication, had a breach in warranties and brought counts of fraud. Wanda is seeking punitive damages and has demanded a jury trial.

The Lipitor Diabetes Lawsuit is Case No. 2:15-cv-3049-RMG in the U.S. District Court for the District of South Carolina, Charleston Division. It is part of the Lipitor Type-2 Diabetes MDL known as In re: Lipitor (Atorvastin Calcium) Marketing, Sales Practices, and Products Liability Litigation, MDL No. 2:14-mn-02502-RMG in the U.S. District Court for the District of South Carolina, Charleston Division.

Lipitor Type-2 Diabetes Connection

Lipitor (atorvastatin calcium) is a statin drug used to lower cholesterol, and it is the top-selling drug of all time. High cholesterol is linked to an increased risk of stroke, heart attack and other serious health conditions.

After thousands of individuals, mostly women, reported developing type-2 diabetes after taking Lipitor, the FDA investigated the situation. In 2012, the FDA required Pfizer to update its labeling to include the risk of developing Type 2 Diabetes.

The warning was a positive step to raise awareness about the potential dangers of the drug, but many women were affected before this new labeling went into effect.

A research study in the BMJ in 2013 looked the data of over 470,000 patients who were new to starting statin drugs including Lipitor, for prevention of cardiovascular events. None of the patients had a prior history of diabetes. Lipitor was among the three types of statin drugs that were linked with an increased incidence of diabetes.

Lipitor Lawsuit and Lipitor MDL Information

When there are so many lawsuits flooding courts across the country, many times the courts move to process the claims through a single court with one judge presiding over the similar cases in an MDL.

This allows for a streamlined approach for pretrial hearings and presentation of evidence that is similar throughout the various cases.

If you or a loved one has developed Type-2 Diabetes after taking Lipitor, you may have a legal claim for compensation. Our experienced attorneys are available to provide free, confidential guidance to you about your eligibility for an individual lawsuit or joining an MDL.